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Abstract Blood glucose (BG) is usually measured after a
caloric restriction of at least 8 h; however evidence-based
recommendations for the duration of a fasting status are
missing. Here we analyze the effect of fasting duration on
levels of BG to determine the minimal fasting duration to
achieve comparable BG levels to conventional fasting
measurements. We used data of a cross-sectional study on
primary care patients, performed in October 2005. We
included 28,024 individuals (age-range 18–99 years; 63%
women) without known diabetes mellitus and without
missing data for BG and fasting status. We computed
general linear models, adjusting for age, sex, time of blood
withdrawal, systolic blood pressure, waist circumference,
total- and HDL-cholesterol, physical activity, smoking,
intake of beta-blocker and alcohol. We tested the intra-
individual variability with respect to fasting status. Overall,
the mean BG differed only slightly between individuals
fasting ≥8 h and those fasting \8 h (men: 5.1 ± 0.8 mmol/
L versus 5.2 ± 1.2 mmol/L; women: 4.9 ± 0.7 mmol/L,
5.0 ± 1.0 mmol/L). After 3 h of fasting differences of BG
diminished in men to −0.08 mmol/L (95%-CI: −0.15;
−0.01 mmol/L), in women to −0.07 mmol/L (−0.12;
−0.03 mmol/L) compared to individuals fasting ≥8h .
Noteworthy, age, time of day of blood withdrawal, physical
activity, and intake of hard liquor inﬂuenced BG levels
considerably. Our data challenge the necessity for a fasting
duration of ≥8 h when measuring blood glucose, suggesting
a random sampling or a fasting duration of 3 h as sufﬁcient.
Rather, our study indicates that essentially more effort on
the assessment of additional external/internal factors on
BG levels is necessary.
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The measurement of blood glucose is a well established
procedure routinely used for many clinical and research
purposes. In epidemiological studies blood glucose is an
often measured parameter be it as a risk factor, mediator or
confounder. Measuring blood glucose requires standard-
ized procedures to minimize variability and bias, both in
terms of required analytical methods and biological vari-
ability. Blood glucose levels are inﬂuenced by external
factors, like caloric intake resulting in an increase of blood
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ing in a decline of blood glucose. In an attempt to obtain
unbiased blood glucose measurements one of the routinely
requested basic requirements for pre-analytical blood
sampling is the fasting state. However the fasting state is
not well deﬁned, i.e. the WHO recommends an 8–14 h (h)
fast [1], the American Diabetes Association (ADA) deﬁnes
fasting as “no caloric intake for at least 8 h” [2] or “an
overnight 8- to 10-h fast” [3]. Moreover, evidence-based
recommendations for the deﬁnition of the duration of the
fasting status are missing—perhaps one reason, why blood
glucose measurements in epidemiological and clinical
studies are carried out inconsistently with regard to fasting
duration. Pre-analytical blood sampling schemes range
from overnight fast, fasting duration between8ha n d
[12 h, ≥12 h, random sampling to even no information at
all.
In the clinical as well as in the research environment, the
required fasting status—however deﬁned—is a challenging
task. For clinicians and patients it would be much simpler
if a blood sample could be taken at any time of the day,
irrespective of the fasting duration. In studies, especially
epidemiological studies, fasting requirement inﬂuences the
study design, complicates the ﬁeld work and increases the
costs of the study. Moreover, and most important, it is not
feasible to reliably control for the self-reported fasting
status.
So far, few studies have examined the association
between fasting duration and blood glucose comprehen-
sively. Most of them studied only the dichotomous
approach of fasting versus non-fasting, using various cut-
points and not taking into account the course of blood
glucose ﬂuctuation according to duration of fasting status.
The aim of our study is to analyze the effect of fasting
duration on levels of blood glucose to determine the min-
imal fasting duration to achieve comparable blood glucose
levels to [8 h fasting measurements. For this purpose we
use the dataset of GEMCAS (GErman Metabolic and
Cardiovascular riSk Project), a recent nationwide study.
Methods
Study design and study participants
GEMCAS was conducted during 2 weeks in October 2005
at 1,511 randomly selected primary care physicians across
Germany. Methods have been previously described in
detail [4, 5]. Brieﬂy, we included all eligible individuals
aged 18–99 years visiting a general practitioner during
these 2 weeks regardless of the reason of their visit and
regardless of their fasting status. The study was planned
and conducted according to the German guidelines for
Good Epidemiology Practices (GEP) [6]. All participants
gave their written informed consent and the study protocol
was approved by the institutional ethics committee.
Data assessment
Data were collected on sociodemographic variables, anti-
hypertensive, lipid-lowering and diabetic medication,
smoking habits, physical activity and time of day of blood
withdrawal. Self-reported physician diagnosed history of
CVD and diabetes mellitus was ﬁlled in by the physician.
Type and time of the last caloric intake (meals and drinks)
were documented, waist circumference and blood pressure
measured according to the study protocol. For blood sam-
pling a two-step approach was performed [5]. First, all
participants underwent a screening by using a blood glu-
cose quick test from a capillary (ﬁnger stick) sample.
Accordingly, it was possible to directly exclude or diag-
nose hyperglycaemia in those participants with a fasting
duration of ≥8 h and a capillary blood glucose of \5.56 or
[11.11 mmol/L. If the ﬁndings concerning fasting serum
glucose were ambiguous (≥5.56 or ≤11.11 mmol/L) due to
a meal in the previous 8 h, the participant was asked to
come for a re-examination to give a fasting blood sample.
Furthermore, a random sample (30%) of participants was
asked to come for a second fasting blood sample, regard-
less of the result of the blood glucose quick test.
Laboratory analysis
For the main analysis a venous blood sample was collected
from each participant, and shipped within 24 h to a central
laboratory (Berlin, Germany) by an assigned courier ser-
vice. Standardised enzymatic methods were used to
determine total cholesterol (T-C), high-density lipoprotein
cholesterol (HDL-C), low-density lipoprotein cholesterol
(LDL-C), and triacylglycerol (TG) using Roche Hitachi
MODULAR systems. Glucose levels from blood in natri-
umﬂuorid (NaF)-tubes were estimated by the glucose-6-
phosphate dehydrogenase method (G6P-DH).
Quality assurance
We implemented a comprehensive quality assurance, per-
forming a special monitoring concept, which included
telephone-monitoring and random on-site visits, recently
described in detail [5].
Diagnostic conventions and covariates
The fasting state was deﬁned by a fasting duration of at
least 8 h. Smoking was deﬁned as current smoking or as a
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123history of cigarette smoking during the past year. Physical
inactivity was set by \2 h/week. The time since last
caloric intake was calculated by generating the difference
between the time of blood withdrawal and time of last
caloric intake (meal or drink) whereas missing data for one
of the two variables was excluded.
Statistical analyses
Of the 35,869 study participants we excluded for the
present analysis those with missing data for blood glucose
(n = 1,236) and fasting status (n = 1,947) as well as
those with a fasting status [35 h (n = 12). Since the
impact of time of last caloric intake on blood glucose
differed markedly between participants with and without
known diabetes mellitus, we further excluded 4,650 par-
ticipants with known diabetes mellitus, leaving a study
sample of 28,024 (mean age 49.9 ± 15.9 years, 63%
women). For analyses, where the exact time since last
caloric intake was necessary, additional 2,489 participants




fasting levels (≥8 h) and the remaining 8 time points (t0,… ,
t7). Tests were corrected for multiple comparisons with the
Bonferroni method. To investigate the relationship between
duration of fasting and age on blood glucose in more detail,
we conducted analysis of covariance. We used continuous
blood glucose as the dependent variable, and time since last
caloric intake as categorical covariate (t1h,… ,t ≥8h as ref-
erence) adjusting for age. To account for possible inﬂuences
of other covariates on blood glucose we used general linear
modelsincludingthevariablesage,sex,timeofdayofblood
withdrawal (dichotomized as morning, \12.00 a.m., and
afternoon), systolic blood pressure, waist circumference,
HDL-cholesterol, total cholesterol, intake of beta-blocker,
physical activity, alcohol intake and smoking status.
Because of the nonlinear relationship between day time of
blood withdrawal and blood glucose a piecewise linear
regressionwasconductedwhichﬁttedoneslopeformorning
and one slope for afternoon appointments.
In sensitivity analysis we compared the intraindividual
variance of blood glucose by computing age- and sex-
adjusted differences between (random) ﬁrst and fasting
(second) blood glucose measurement stratiﬁed by the time
of last caloric intake at the ﬁrst. The (random) intra-indi-
vidual variance was assessed by the standard deviation of
the test–retest differences (SDdiff) of the means (measure-
ment 1 minus measurement 2) with their 95% conﬁdence
intervals (CI) [7]. The SDdiff can easily be interpreted as
95% of the random test–rest differences will be less than
2*SDdiff [8]. All statistical analyses were conducted using
SAS 9.2 (SAS Institute, Cary, NC, USA).
Results
Characteristics of study population and duration
of fasting status
Characteristics of the study population stratiﬁed by the
duration of fasting status are shown in eTable 1. Striking
differences according to fasting duration, independent from
age, could not be observed. Figure 1 demonstrates a
bimodal distribution of fasting duration on the survey day.
About 50% of the participants reported a fasting duration
of less then 4 h, 28% more than ≥8 h. Only very few
participants had a fasting duration of 7 h or 8 h.
Especially in men the proportion of study participants
with a fasting duration ≥8 h decreased with age (\36 years:
34%, 36–59 years: 30%, 60–80 years: 25%, [80 years:
19%; women resp. 26, 23, 21, 20%).
Blood glucose levels and fasting status
Overall, mean blood glucose levels differed only slightly
between fasting and non-fasting individuals: 5.1 ± 0.8
mmol/L in fasting men, 5.2 ± 1.2 mmol/L in non-fasting
men; resp. women 4.9 ± 0.7, 5.0 ± 1.0 mmol/L. Table 1
depicts an age-effect in men, with lowest differences
between fasting and non-fasting men in the youngest age-
group(+0,012mmol/L)andhighestdifferencesintheoldest
age-group ≥80 years (-0.302 mmol/L), reﬂecting a deterio-
rating effect of the glucose metabolism with increasing age.
This age-effect is not observable in women, but like in men,
the oldest women showed the highest blood glucose differ-
ences (-0.032 mmol/L), even though on a much lower mean
blood glucose level.
Blood glucose levels and hours of last caloric intake
Figure 2illustrates the course of age- and sex-adjustedmean
bloodglucoselevelsaccordingtohoursoflastcaloricintake.
Blood glucose levels of individuals with less than 3 h of
fasting were higher compared to blood glucose levels of
individuals with a fasting duration of 8 to more than 18 h
(t0h = 5.3 mmol/L, t2h = 5.2 mmol/L, t8h = 5.0 mmol/L).
However, after this time period blood glucose levels are
even lower (t4h,t 5h) or do not differ anymore (t6h − t7h).
Additionally, stratifying for sex and controlling for time
of day did not inﬂuence the effect of duration since last
caloric intake (eTable 2). Despite the well-known fact of a
pronounced age effect on blood glucose levels, the above
described time pattern of changes of blood glucose and
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[80 years (Fig. 3).
Control of external inﬂuence factors
Table 2 shows the sex-speciﬁc impact of fasting duration on
blood glucose levels additionally adjusted for waist cir-
cumference, metabolic and lifestyle factors. With each
additional hour of fasting the blood glucose decreases by
about0.024mmol/L(≙0.4mg/dL)inmenand0.009mmol/L
(≙0.2 mg/dL) in women. Theoretically, adding this up to 8 h
(irrespectiveofdayofbloodsampling)thisamountstoabout
3 mg/dL in men and about 2 mg/dL in women, conﬁrming
the above reported results of marginal higher blood glucose
levels comparing fasting and non-fasting blood glucose
concentrations.Inadditiontothewellknownassociationsof
blood glucose with CVD risk factors (lipids, blood pressure,
obesity), we observed a strong association with time of day
of blood sampling (Table 2). Notably this association was


























Fig. 1 Distribution of fasting duration on the survey day (n = 25,535)
Table 1 Difference of mean blood glucose levels (mmol/L) between fasting and non-fasting men and women
Age-groups Fasting status Difference
a
Fasting (≥8 h) Non-fasting (\8h )
(years) n Mean ± SD n Mean ± SD P value*
Men
\36 618 4.79 ± 0.61 1,206 4.78 ± 0.86 0.012 0.74
36–59 1,613 5.13 ± 0.86 3,785 5.21 ± 1.19 −0.082 0.0045
60–80 759 5.37 ± 0.84 2,242 5.50 ± 1.34 −0.128 0.0022
≥80 38 5.43 ± 0.65 167 5.73 ± 1.46 −0.302 0.0529
All 3,028 5.13 ± 0.83 7,400 5.24 ± 1.22 −0.115 \0.001
Women
\36 924 4.57 ± 0.49 2,602 4.60 ± 0.69 −0.032 0.1272
36–59 2,196 4.91 ± 0.63 7,356 4.95 ± 0.92 −0.037 0.0303
60–80 868 5.21 ± 0.81 3,260 5.23 ± 1.09 −0.018 0.5864
≥80 79 5.27 ± 0.74 311 5.43 ± 1.14 −0.162 0.1261
All 4,067 4.90 ± 0.69 13,529 5.0 ± 0.96 −0.056 \0.001
Fasting: last caloric intake ≥8 h, non-fasting: last caloric intake \8h
* P values refer to t-tests differences between fasting and nonfasting blood glucose in each age-and sex-speciﬁc group
a Difference = (last caloric intake ≥ 8h )− (last caloric intake \8h )
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123demonstrating a bidirectional trend between sampling in the
morning and in the afternoon.
Sensitivity analyses
As expected, the intra-individual variability differed with
regard to fasting status on two consecutive measurements.
The spearman correlation coefﬁcient was highest with a
fasting status at both measurements, reaching 0.625
(eFigure 1). The coefﬁcient diminished to 0.388 comparing
a ﬁrst random versus a second fasting measurement, which
did not differ from two consecutive measurements both at
random (0.386).
However, the mean age- and sex-adjusted difference
between a ﬁrst (random) and a second (fasting) blood
glucose measurement, stratiﬁed by fasting duration at the
ﬁrst measurement (eFigure 2), shows the highest difference
(+0.66 mmol/L) when fasting status is less than 1 h
compared to the fasting blood glucose at the second mea-
surement and no differences when fasting was ≥4h ,
conﬁrming the previous results. Restriction of this analysis
to the random sample of participants did not change our
results substantially.
Differences in blood glucose between ﬁrst and second
measurement were remarkable small regardless of fasting
status of ﬁrst and second measurement (fasting/fasting,
Fig. 2 Age- and sex-adjusted blood glucose levels by time since last caloric intake (n = 25,535)
Fig. 3 Sex-adjusted blood glucose levels by time since last caloric intake stratiﬁed by age-groups
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123non-fasting/fasting, etc.), despite a lower variance—
expressed as the standard deviation of the mean difference
—in the fasting/fasting combination (Table 3).
At least we tested intra-individual changes of assign-
ment to blood glucose-risk categories (low: \5.6 mmol/L,
medium: 5.6–7.0 mmol/L, high ≥ 7.0 mmol/L) at the
repeated second fasting measurement compared to differ-
ent fasting durations (≥8, [0, ≥3 h) at ﬁrst measurement.
We found that 91.8% of those individuals with a low
fasting blood glucose (≥8 h) at ﬁrst measurement remained
in the low category at the repeated measurement (Table 4).
This proportion attenuated slightly comparing those with a
random fasting ([0 h) and a fasting status ≥3 h at ﬁrst
measurement (90.6%, resp. 89.3%). On the other hand, in
only 22.2% of the individuals with a fasting duration ≥8h ,
resp. 18.4% with a fasting duration ≥3 h and 11.3% with a
random measurement, a high blood glucose level could be
conﬁrmed at the second measurement. Hence, transitions
between the medium and high categories were high—
independent of fasting duration at ﬁrst and second
measurement.
Discussion
In our study population of women and men, aged 18–
99 years, the minimal fasting duration to achieve compa-
rable blood glucose levels between fasting and non-fasting
measurements was 3 h. Overall, mean blood glucose levels
differed only marginally between fasting and non-fasting
individuals. Although the variance of blood glucose was
higher in men and older individuals, the results are inde-
pendently from age and sex. This pattern persisted even
when taking into account varying waist circumference,
metabolic and lifestyle factors. Analyzing intraindividual
changes between non-fasting and fasting measurements
conﬁrmed these results, underlining the robustness of our
ﬁndings. Moreover, our data show strong associations
between blood glucose levels and time of day of blood
Table 2 Association between blood glucose and fasting duration, time of blood sampling and personal characteristics stratiﬁed by sex
Men Women
Change of blood glucose (mmol/L) Change of blood glucose (mmol/L)
ß 95%-CI ß 95%-CI
Age (years) 0.010 0.008; 0.011 0.010 0.009; 0.012
Fasting duration (h) −0.024 −0.029; −0.018 −0.009 −0.013; −0.006
Time of day of blood sampling
Morning (\12.00 p.m.) −0.052 −0.075; −0.029 −0.027 −0.042; −0.011
Afternoon (≥ 12.00 p.m.) 0.011 −0.015; 0.037 0.020 0.005; 0.035
HDL-cholesterol (mmol/L) −0.120 −0.189; −0.050 −0.095 −0.132; −0.058
Total cholesterol (mmol/L) −0.003 −0.026; 0.021 0.018 0.001; 0.034
Systole blood pressure (mmHg) 0.004 0.002; 0.005 0.002 0.002; 0.003
Intake of beta-blocker 0.160 0.100; 0.220 0.152 0.111; 0.193
Waist circumference (cm) 0.010 0.008; 0.012 0.008 0.006; 0.009
Smoking 0.048 −0.004; 0.100 0.022 −0.013; 0.056
Beverage
Soft/ﬁzzy drinks
a 0.004 −0.054; 0.062 0.046 0.001; 0.089
Hard liquor
a 0.234 0.053; 0.414 0.212 0.014; 0.409
Physical activity (ref. \2 h/week) −0.096 −0.150; −0.042 −0.034 −0.069; 0.001
a Reference for beverages = never and seldom
Table 3 Sex-speciﬁc intraindividual variability in blood glucose
measured by two consecutive appointments according to fasting status
Δmeasurement 1 − measurement 2 (mmol/L)
n Meandif 95%-CI SDdif
Men
Fasting–fasting 612 0.047 −0.004; 0.099 0.653
Non fasting–fasting 3,099 0.344 0.301; 0.388 1.234
Fasting–nonfasting 64 −0.053 −0.274; 0.168 0.886
Nonfasting–nonfasting 425 0.024 −0.102; 0.150 1.320
Women
Fasting–fasting 664 0.112 0.051; 0.172 0.794
Non fasting–fasting 4,472 0.275 0.247; 0.304 0.975
Fasting–nonfasting 94 −0.130 −0.313; 0.053 0.892
Nonfasting–nonfasting 729 0.153 0.072; 0.233 1.108
SDdif standard deviation of the ﬁrst and second measurement
differences
Fasting ≥8 h, non-fasting \8 h since last caloric intake, 95%-CI: 95%
conﬁdence interval
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123withdrawal, regular physical activity or drinking of hard
liquor.
Fasting versus non-fasting blood glucose measurements
To the best of our knowledge, evidence is missing demon-
strating that blood glucose measurements with a fasting
duration of more than 8 h do better than those with less than
8 h of fasting duration. The main argument for fasting glu-
cose measurements is the rise in blood glucose levels seen
after a caloric meal or drink, especially during an oral glu-
cose tolerance test (oGTT) [9]. However, our data show
higher mean blood glucose levels only in the ﬁrst 3 h after a
caloric intake. This observation is in line with an earlier
study from the ﬁfties [10] and the ADA in 2001, stating that
in nondiabetic individuals, blood glucose levels return to
preprandial levels within 2–3 h [11]. In the British Regional
Heart Study, a cross-sectional study of 60–79 year old men
[12], no difference of blood glucose levels between fasting
\6 h versus ≥6 h were found (5.6 mmol/L resp. 5.7 mmol/
L), which is in accordance to our results (Table 1). Further
studies—mainlyfocussingontheeffectofdiurnalvariations
of blood glucose levels or postprandial glucose metabolism
—report a decrease of blood glucose to normal blood glu-
cose levels 2–3 h after an oral glucose tolerance test or test
meal[9,13–15],supportingourﬁndingsofsmalldifferences
between fasting and non-fasting glucose levels.
To maintainglucosehomeostasis, the human body isable
to tightly regulate levels of circulating blood glucose by
coupling nutrient-stimulated insulin secretion (insulin
response) and the metabolic action of insulin to stimulate
glucose disposal [16]. In individuals with diabetes the glu-
cose homeostatis is disturbed. Diabetics not only exceed
normal blood glucose levels, but also experience high blood
glucose ﬂuctuations,with a higher increase of blood glucose
after caloric intake and a prolonged decrease to baseline
levels compared to normal individuals. Thus we excluded
participantswith knowndiabetes mellitus fromouranalysis.
Increasing age is associated with increasing impairment
of the glucose homeostasis, possibly due to a decreasing
insulin secretory capacity or insulin action [17]. Our data
show higher blood glucose differences between fasting and
non-fasting participants in the oldest age-group, especially
in men (Table 1). However, these differences are rather low
and they seem to be no reason for a fasting duration of
more than 3 h.
Blood glucose levels are inﬂuenced by analytical con-
ditions [18] and (intra-individual) biologic variations [19–
22]. The latter is dependent on a number of factors like
time of day, medication intake prior exercise status or
alcohol intake [22–25]. The observed maximum age- and
sex-adjusted blood glucose increase in our study of
0.3 mmol/L (≙5.4 mg/dL) with regard to duration of last
caloric intake is very like within the variation of these
biologic factors.
Strengths and limitations
One strength of our study is the large sample size and the
broad age-range, allowing us to study the inﬂuence of age
Table 4 Intraindividual change of blood glucose categories at second (fasting) measurement compared to a fasting duration of ≥8h ,[0h
(random) and ≥3 h at ﬁrst measurement
1. Measurement 2. Fasting measurement ≥ 8h
Fasting duration (h) Blood glucose category
a Low Medium High All
%n %n%n% n
≥8 Low 91.8 938 7.9 81 0.3 3 80.2 1,022
[0 (random) 90.6 4,966 8.7 479 0.7 37 72.5 5,482
≥3 89.3 2,473 10.3 278 0.7 20 79.6 2,771
≥8 Medium 48.2 109 45.6 103 6.2 14 17.7 226
[0 (random) 77.0 1,220 21.6 343 1.4 22 21.0 1,585
≥3 67.0 382 30.9 176 2.1 12 21.0 1,101
≥8 High 40.7 11 37.0 10 22.2 6 2.1 27
[0 (random) 57.5 284 31.2 154 11.3 56 6.5 494
≥3 48.9 69 32.6 46 18.4 26 4.1 141
≥8 All 83.0 1,085 15.2 194 1.8 23 100 1,275
[0 (random) 85.6 6,470 12.9 976 1.5 115 100 7,561
≥3 84.0 2,924 14.4 500 1.7 58 100 3,482
a Categories deﬁned as a low blood glucose \5.6 mmol/L, medium blood glucose 5.6–7.0 mmol/L, high blood glucose ≥7.1 mmol/L
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ated blood glucose measurement in a subsample of
participants. Thus, we were able to determine in sensitivity
analyses directly the intra-individual variability with
respect to fasting status. Since time of last caloric intake
was self-reported and therefore subject to error, partici-
pants not only were asked by the doctor for the exact time
of last caloric intake, but additionally for the type of last
meal and drink. Accordingly, participants more likely
remember the right time, which in turn should reduce this
potential recall bias. In any case, other methods to measure
last caloric intake with less bias are apparently unaccept-
able for study participants or patients. Our participants
were mostly white and recruited from different geograph-
ically located general practices across Germany. Thus our
results may not apply to other ethnic groups. A detailed
discussion of possible selection bias of our study is pro-
vided in [5]. Brieﬂy, characteristics of this primary health
care sample are comparable to other German population-
based samples and to the German federal statistical data
with regard to anthropometric measures, smoking status,
marital status, schooling and unemployment rate (i.e.
GEMCAS: 10.2%, Germany October 2005: 10.4%). This
high conformance might be explained by the situation that
92% of adults in Germany consult a general practitioner
during 1 year [26]. However, the proportion of participants
with diabetes and CVD is higher than compared to popu-
lation-based samples, but still lower than in real patient-
based samples [5]. We found differences in demographic
characteristics in fasting versus non-fasting individuals. To
account for these differences we stratiﬁed by sex and age-
groups and estimated adjusted associations; nonetheless
residual confounding in this observational study might still
be an issue. Overall, our results have to be interpreted in
terms of the observational nature of our study.
Implications for blood sampling in clinical practice and
research
Possibleimplicationsforblood sampling regimes depend on
the intention of blood glucose measurements. In clinical
practice blood glucose is basically measured in order to
obtain information about the existence and extent (control
andtreatmentofdiabetes)ofadisturbedglucosemetabolism
(diagnosis of diabetes mellitus). According to recommen-
dations of international experts a diagnosis of diabetes
mellitus is possible in different ways: random or fasting
blood glucose measurement or oGTT. For the ADA a con-
ﬁrmation of the test on a subsequent day is mandatory in the
absenceofunequivocalhyperglycemia[27].Inthissensethe
recommendation of the WHO is even stricter stating “… the
diagnosis of diabetes in an asymptomatic subject should
never be made on the basis of a single abnormal blood
glucose value. For the asymptomatic person, at least one
additional plasma/blood glucose test result with a value in
the diabetic range is essential, either fasting, from a random
(casual) sample, or from the OGTT” [1]. The importance of
a replicate test is supported by our data, showing high
transition rates between medium and high blood glucose
categories—independent of fasting duration. Thus, several
methods for a diagnosis of diabetes are already available,
allowing clinicians to apply the most advantageous method
in their everyday practice and the most convenient method
for their patients.
One argument in favour of recommending a fasting
measurement might be the often concurrent determination
of lipid proﬁles for CVD risk assessment. However,
according to recent studies [28–32] and recommendations
[33–36] fasting blood glucose measurements for clinical
purposes are not necessary in the ﬁrst place, even in
combination with the determination of lipid proﬁles for
CDV risk assessment.
Implications for research purposes depend on the study
question to be studied. (1) Aetiological studies aiming to
understand glucose metabolism or the development of dia-
betes mellitus certainly need highly standardized conditions
concerning fasting status. Anyhow, our results conﬁrm that
—beyond the fasting status—a thorough control of a wide
range of factors is necessary to achieve unbiased measure-
ments. (2) In epidemiological studies blood glucose is often
measuredasriskfactor,mediatororconfounder.Inthiscase,
our results not only challenge the current need of a fasting
duration of more than 8 h, but also suggest a random sam-
pling accomplished by a detailed assessment of last caloric
intakeor—iffeasible—afastingdurationof3hassufﬁcient.
As discussed above, fasting measurements are not neces-
sarily unbiased, as marked variations due to a wide range of
external and internal inﬂuencing factors still occur.
In conclusion, our data challenge the necessity for a
fasting duration of [8 h when measuring blood glucose. A
random blood glucose sample or a fasting duration of 3 h
seems sufﬁcient for reliable blood glucose measurements.
Rather, our study indicates that essentially more effort on
the assessment of additional external/internal factors on
blood glucose levels is necessary. Blood glucose assess-
ment should be accomplished by a detailed assessment of
last caloric meal and drink as well as a thorough assess-
ment of alcohol consumption, medication intake, exercise
status, and time of day of blood sampling. Further studies
are warranted, systematically studying the effect of dif-
ferent fasting duration on blood glucose levels. In case of a
conﬁrmation of our results, this would simplify routines in
clinical practices for both the clinicians and the patients
and would facilitate the scheduling appointments at epi-
demiological studies with a considerable cost reducing
effect.
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